Anaveon
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.
Anaveon has raised €136M across 2 funding rounds from 7 investors, most recently a Series B round in Dec 2021. Based in Zurich, Switzerland; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€136M
€136,251,350
Funding rounds
2
Investors
7
distinct backers
Active since
2019-01
latest 2021-12
Funding by year
EUR raised per yearAnaveon — funding by year — interactive chart.
Data table
| Anaveon — funding by year | |
|---|---|
| 2018 | €31M |
| 2021 | €105M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-16 | Series B | €105M | Cowen Healthcare Investments,Forbion,Novartis Venture Fund,Pfizer Ventures,Pontifax Funds,Syncona Partners | View deal → |
| 2019-01-01 | Series A | €31M | Syncona Partners | View deal → |
Investors
7Related news
- Anaveon raises CHF 110 millionstartupticker.ch · 2021-12
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData